Multiplex Assay Kit for Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay)

BDK; KNG; HMWK; Alpha-2-Thiol Proteinase Inhibitor; Bradykinin; Kallidin; Fitzgerald factor; High molecular weight kininogen; Williams-Fitzgerald-Flaujeac factor; Ile-Ser-Bradykinin

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-103 95
EDTA plasma(n=5) 96-105 101
heparin plasma(n=5) 78-98 81

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-94% 91-101% 93-102% 78-96%
EDTA plasma(n=5) 96-103% 87-103% 84-96% 97-105%
heparin plasma(n=5) 88-102% 92-99% 88-97% 95-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:KNG1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS One Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis PubMed: 26098644
Universität Leipzig, Dissertation Einfluss zyklischer mechanischer Dehnung auf das Kinin-Kallikrein-System in alveolären Typ-II-Zellen der Ratte 21931
Biomedicine & Pharmacotherapy Evaluation of the anti-hypertensive effect of Tengfu Jiangya tablet by combination of UPLC-Q-exactive-MS-based metabolomics and iTRAQ-based proteomics … Pubmed:29453042
Clinical and Applied Thrombosis/Hemostasis Contact System Activation and Neutrophil Extracellular Trap Markers: Risk Factors for Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma Doi: 10.1177/1076029618825310
experimental and clinical endocrinology & diabetes Activation of Factor XII and Kallikrein-kinin System Combined with Neutrophil Extracellular Trap Formation in Diabetic Retinopathy Pubmed: 31426112
Einfluss mechanischer Dehnung von alveolaren Typ-II-Zellen auf die Bildung von Bradykinin durch das Kallikrein-Kinin-System
Scientific Reports Maternal Serum Proteomic Profiles of Pregnant Women With Type 1 Diabetes 34940989
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB267Ra01 Recombinant Kininogen 1 (KNG1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB267Ra01 Polyclonal Antibody to Kininogen 1 (KNG1) WB; IHC; ICC; IP.
MAB267Ra21 Monoclonal Antibody to Kininogen 1 (KNG1) WB; IHC; ICC; IP.
SEB267Ra ELISA Kit for Kininogen 1 (KNG1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB267Ra Multiplex Assay Kit for Kininogen 1 (KNG1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB267Ra01 ELISA Kit DIY Materials for Kininogen 1 (KNG1) Main materials for "Do It (ELISA Kit) Yourself".